Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Effects of fish oil supplementation on eicosanoid production in patients at higher risk for colorectal cancer.

White MN, Shrubsole MJ, Cai Q, Su T, Hardee J, Coppola JA, Cai SS, Martin SM, Motley S, Swift LL, Milne GL, Zheng W, Dai Q, Murff HJ.

Eur J Cancer Prev. 2019 May;28(3):188-195. doi: 10.1097/CEJ.0000000000000455.

PMID:
30640206
2.

Arachidonic acid and colorectal adenoma risk: a Mendelian randomization study.

Isom CA, Shrubsole MJ, Cai Q, Smalley WE, Ness RM, Zheng W, Murff HJ.

Clin Epidemiol. 2018 Dec 18;11:17-22. doi: 10.2147/CLEP.S186883. eCollection 2019.

3.

Metformin use and incidence cancer risk: evidence for a selective protective effect against liver cancer.

Murff HJ, Roumie CL, Greevy RA, Hackstadt AJ, McGowan LED, Hung AM, Grijalva CG, Griffin MR.

Cancer Causes Control. 2018 Sep;29(9):823-832. doi: 10.1007/s10552-018-1058-4. Epub 2018 Jul 18.

4.

A prospective study of dietary polyunsaturated fatty acids intake and lung cancer risk.

Luu HN, Cai H, Murff HJ, Xiang YB, Cai Q, Li H, Gao J, Yang G, Lan Q, Gao YT, Zheng W, Shu XO.

Int J Cancer. 2018 Nov 1;143(9):2225-2237. doi: 10.1002/ijc.31608. Epub 2018 Aug 7.

PMID:
29905376
5.

Inter-niche and inter-individual variation in gut microbial community assessment using stool, rectal swab, and mucosal samples.

Jones RB, Zhu X, Moan E, Murff HJ, Ness RM, Seidner DL, Sun S, Yu C, Dai Q, Fodor AA, Azcarate-Peril MA, Shrubsole MJ.

Sci Rep. 2018 Mar 7;8(1):4139. doi: 10.1038/s41598-018-22408-4.

6.

Review: Weak evidence of benefits of cannabis for chronic neuropathic pain; moderate to weak evidence of adverse effects.

Murff HJ.

Ann Intern Med. 2017 Dec 19;167(12):JC62. doi: 10.7326/ACPJC-2017-167-12-062. No abstract available.

PMID:
29255852
7.

Self-monitoring of blood glucose did not improve HbA1c or QoL at 1 year in non-insulin-treated type 2 diabetes.

Murff HJ.

Ann Intern Med. 2017 Oct 17;167(8):JC46. doi: 10.7326/ACPJC-2017-167-8-046. No abstract available.

PMID:
29049765
8.

PUFA levels in erythrocyte membrane phospholipids are differentially associated with colorectal adenoma risk.

Rifkin SB, Shrubsole MJ, Cai Q, Smalley WE, Ness RM, Swift LL, Zheng W, Murff HJ.

Br J Nutr. 2017 Jun;117(11):1615-1622. doi: 10.1017/S0007114517001490. Epub 2017 Jun 29.

9.

Review: In adults with diabetes, aspirin does not prevent CV events compared with placebo.

Murff HJ.

Ann Intern Med. 2016 Nov 15;165(10):JC53. doi: 10.7326/ACPJC-2016-165-10-053. No abstract available.

PMID:
27842390
10.

Comparative Effectiveness of Second-Line Agents for the Treatment of Diabetes Type 2 in Preventing Kidney Function Decline.

Hung AM, Roumie CL, Greevy RA, Grijalva CG, Liu X, Murff HJ, Ikizler TA, Griffin MR.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2177-2185. Epub 2016 Nov 8.

11.

Smoking and red blood cell phospholipid membrane fatty acids.

Murff HJ, Tindle HA, Shrubsole MJ, Cai Q, Smalley W, Milne GL, Swift LL, Ness RM, Zheng W.

Prostaglandins Leukot Essent Fatty Acids. 2016 Sep;112:24-31. doi: 10.1016/j.plefa.2016.08.004. Epub 2016 Aug 16.

12.

Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium.

Khankari NK, Murff HJ, Zeng C, Wen W, Eeles RA, Easton DF, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Donovan JL, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, Zheng W; PRACTICAL consortium.

Br J Cancer. 2016 Aug 23;115(5):624-31. doi: 10.1038/bjc.2016.228. Epub 2016 Aug 4.

13.

Endogenous Production of Long-Chain Polyunsaturated Fatty Acids and Metabolic Disease Risk.

Murff HJ, Edwards TL.

Curr Cardiovasc Risk Rep. 2014 Dec 1;8(12). pii: 418.

14.

The role of matching when adjusting for baseline differences in the outcome variable of comparative effectiveness studies.

Grijalva CG, Roumie CL, Murff HJ, Hung AM, Beck C, Liu X, Griffin MR, Greevy RA Jr.

J Comp Eff Res. 2015 Aug;4(4):341-9. doi: 10.2217/cer.15.16.

15.

Thiazolidinedione and Metformin Use and the Risk of Benign Prostate Hyperplasia in Veterans with Diabetes Mellitus.

Murff HJ, Roumie CL, Greevy RA, Grijalva CG, Hung AH, Liu X, Griffin MR.

J Mens Health. 2014 Dec 1;11(4):157-162.

16.

Plasma lipid levels and colorectal adenoma risk.

Coppola JA, Shrubsole MJ, Cai Q, Smalley WE, Dai Q, Ness RM, Fazio S, Zheng W, Murff HJ.

Cancer Causes Control. 2015 Apr;26(4):635-43. doi: 10.1007/s10552-015-0555-y. Epub 2015 Mar 12.

17.

Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes.

Roumie CL, Greevy RA, Grijalva CG, Hung AM, Liu X, Murff HJ, Elasy TA, Griffin MR.

JAMA. 2014 Jun 11;311(22):2288-96. doi: 10.1001/jama.2014.4312.

18.

Genome-wide association study identifies possible genetic risk factors for colorectal adenomas.

Edwards TL, Shrubsole MJ, Cai Q, Li G, Dai Q, Rex DK, Ulbright TM, Fu Z, Delahanty RH, Murff HJ, Smalley W, Ness RM, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1219-26. doi: 10.1158/1055-9965.EPI-12-1437. Epub 2013 May 15.

19.

Exploring the frontier of electronic health record surveillance: the case of postoperative complications.

FitzHenry F, Murff HJ, Matheny ME, Gentry N, Fielstein EM, Brown SH, Reeves RM, Aronsky D, Elkin PL, Messina VP, Speroff T.

Med Care. 2013 Jun;51(6):509-16. doi: 10.1097/MLR.0b013e31828d1210.

20.

Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control.

Hung AM, Roumie CL, Greevy RA, Liu X, Grijalva CG, Murff HJ, Griffin MR.

Pharmacoepidemiol Drug Saf. 2013 Jun;22(6):623-31.

21.

Validation of VA administrative data algorithms for identifying cardiovascular disease hospitalization.

Niesner K, Murff HJ, Griffin MR, Wasserman B, Greevy R, Grijalva CG, Roumie CL.

Epidemiology. 2013 Mar;24(2):334-5. doi: 10.1097/EDE.0b013e3182821e75. No abstract available.

22.

Who said it? Establishing professional attribution among authors of Veterans' Electronic Health Records.

Reeves RM, FitzHenry F, Brown SH, Kotter K, Gobbel GT, Montella D, Murff HJ, Speroff T, Matheny ME.

AMIA Annu Symp Proc. 2012;2012:753-62. Epub 2012 Nov 3.

23.

Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study.

Roumie CL, Hung AM, Greevy RA, Grijalva CG, Liu X, Murff HJ, Elasy TA, Griffin MR.

Ann Intern Med. 2012 Nov 6;157(9):601-10. doi: 10.7326/0003-4819-157-9-201211060-00003.

24.

Reweighted Mahalanobis distance matching for cluster-randomized trials with missing data.

Greevy RA Jr, Grijalva CG, Roumie CL, Beck C, Hung AM, Murff HJ, Liu X, Griffin MR.

Pharmacoepidemiol Drug Saf. 2012 May;21 Suppl 2:148-54. doi: 10.1002/pds.3260.

25.

A study of prostaglandin pathway genes and interactions with current nonsteroidal anti-inflammatory drug use in colorectal adenoma.

Edwards TL, Shrubsole MJ, Cai Q, Li G, Dai Q, Rex DK, Ulbright TM, Fu Z, Murff HJ, Smalley W, Ness R, Zheng W.

Cancer Prev Res (Phila). 2012 Jun;5(6):855-63. doi: 10.1158/1940-6207.CAPR-11-0459. Epub 2012 May 2.

26.

Obesity and colorectal cancer screening among black and white adults.

Cohen SS, Murff HJ, Signorello LB, Blot WJ.

Cancer Causes Control. 2012 May;23(5):709-16. doi: 10.1007/s10552-012-9941-x. Epub 2012 Mar 23.

27.

Dietary intake of PUFAs and colorectal polyp risk.

Murff HJ, Shrubsole MJ, Cai Q, Smalley WE, Dai Q, Milne GL, Ness RM, Zheng W.

Am J Clin Nutr. 2012 Mar;95(3):703-12. doi: 10.3945/ajcn.111.024000. Epub 2012 Jan 25.

28.

Comparative effectiveness of incident oral antidiabetic drugs on kidney function.

Hung AM, Roumie CL, Greevy RA, Liu X, Grijalva CG, Murff HJ, Ikizler TA, Griffin MR.

Kidney Int. 2012 Apr;81(7):698-706. doi: 10.1038/ki.2011.444. Epub 2012 Jan 18.

29.

ACP Journal Club. Review: cholecalciferol (vitamin D3) reduces mortality in adults; other forms of vitamin D do not.

Murff HJ.

Ann Intern Med. 2011 Nov 15;155(10):JC5-04. doi: 10.7326/0003-4819-155-10-201111150-02004. No abstract available.

PMID:
22084351
30.
31.

Automated identification of postoperative complications within an electronic medical record using natural language processing.

Murff HJ, FitzHenry F, Matheny ME, Gentry N, Kotter KL, Crimin K, Dittus RS, Rosen AK, Elkin PL, Brown SH, Speroff T.

JAMA. 2011 Aug 24;306(8):848-55. doi: 10.1001/jama.2011.1204.

PMID:
21862746
32.

Nonsteroidal anti-inflammatory drug use and risk of adenomatous and hyperplastic polyps.

Murff HJ, Shrubsole MJ, Chen Z, Smalley WE, Chen H, Shyr Y, Ness RM, Zheng W.

Cancer Prev Res (Phila). 2011 Nov;4(11):1799-807. doi: 10.1158/1940-6207.CAPR-11-0107. Epub 2011 Jul 15.

33.

“Near-miss” Reporting System Development and Implications for Human Subjects Protection.

Murff HJ, Byrne DW, Harris PA, France DJ, Hedstrom C, Dittus RS.

In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in Patient Safety: From Research to Implementation (Volume 3: Implementation Issues). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Feb.

34.

The effect of incident antidiabetic regimens on lipid profiles in veterans with type 2 diabetes: a retrospective cohort.

Roumie CL, Huizinga MM, Liu X, Greevy RA, Grijalva CG, Murff HJ, Hung AM, Griffin MR.

Pharmacoepidemiol Drug Saf. 2011 Jan;20(1):36-44. doi: 10.1002/pds.2029. Epub 2010 Nov 12.

PMID:
21182152
35.

ACP Journal Club. Colorectal cancer screening with fecal immunochemical testing had higher adherence than screening with guaiac-based FOBT.

Murff HJ.

Ann Intern Med. 2010 Oct 19;153(8):JC4-5. doi: 10.7326/0003-4819-153-8-201010190-02005. No abstract available.

PMID:
20956701
36.

Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: a prospective cohort study.

Murff HJ, Shu XO, Li H, Yang G, Wu X, Cai H, Wen W, Gao YT, Zheng W.

Int J Cancer. 2011 Mar 15;128(6):1434-41. doi: 10.1002/ijc.25703. Epub 2010 Nov 23.

37.

Glycemic and weight changes after persistent use of incident oral diabetes therapy: a Veterans Administration retrospective cohort study.

Huizinga MM, Roumie CL, Greevy RA, Liu X, Murff HJ, Hung AM, Grijalva CG, Griffin MR.

Pharmacoepidemiol Drug Saf. 2010 Nov;19(11):1108-12. doi: 10.1002/pds.2035.

PMID:
20878643
38.

The association of plasma fatty acids with prostate cancer risk in African Americans and Africans.

Ukoli FA, Fowke JH, Akumabor P, Oguike T, Taher KA, Murff HJ, Amaefuna ER, Kittles R, Ahaghotu C, Osime U, Beech DJ.

J Health Care Poor Underserved. 2010 Feb;21(1 Suppl):127-47. doi: 10.1353/hpu.0.0242.

PMID:
20173289
39.

A prospective study of dietary polyunsaturated fatty acids and colorectal cancer risk in Chinese women.

Murff HJ, Shu XO, Li H, Dai Q, Kallianpur A, Yang G, Cai H, Wen W, Gao YT, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2283-91. doi: 10.1158/1055-9965.EPI-08-1196.

40.

Use of thiazolidinediones does not affect prostate-specific antigen levels in men with diabetes.

Pini TM, Griffin MR, Roumie CL, Huizinga MM, Fowke JH, Greevy R, Liu X, Murff HJ.

Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1937-8. doi: 10.1158/1055-9965.EPI-09-0215. Epub 2009 May 19.

41.

Detection of blood culture bacterial contamination using natural language processing.

Matheny ME, Fitzhenry F, Speroff T, Hathaway J, Murff HJ, Brown SH, Fielstein EM, Dittus RS, Elkin PL.

AMIA Annu Symp Proc. 2009 Nov 14;2009:411-5.

42.

Race and socioeconomic status are independently associated with benign prostatic hyperplasia.

Fowke JH, Murff HJ, Signorello LB, Lund L, Blot WJ.

J Urol. 2008 Nov;180(5):2091-6; discussion 2096. doi: 10.1016/j.juro.2008.07.059. Epub 2008 Sep 18.

43.

Papanicolaou testing among women in the southern United States.

Peterson NB, Murff HJ, Cui Y, Hargreaves M, Fowke JH.

J Womens Health (Larchmt). 2008 Jul-Aug;17(6):939-46. doi: 10.1089/jwh.2007.0576.

44.

Colonoscopy screening in African Americans and Whites with affected first-degree relatives.

Murff HJ, Peterson NB, Fowke JH, Hargreaves M, Signorello LB, Dittus RS, Zheng W, Blot WJ.

Arch Intern Med. 2008 Mar 24;168(6):625-31. doi: 10.1001/archinte.168.6.625.

45.

Use of colonoscopy and flexible sigmoidoscopy among African Americans and whites in a low-income population.

Peterson NB, Murff HJ, Fowke JH, Cui Y, Hargreaves M, Signorello LB, Blot WJ.

Prev Chronic Dis. 2008 Jan;5(1):A28. Epub 2007 Dec 15. No abstract available.

46.

Changing incident diabetes regimens: a Veterans Administration cohort study from 2000 to 2005.

Huizinga MM, Roumie CL, Elasy TA, Murff HJ, Greevy R, Liu X, Speroff T, Griffin M.

Diabetes Care. 2007 Aug;30(8):e85. No abstract available.

PMID:
17855270
47.

Research participant safety and systems factors in general clinical research centers.

Murff HJ, Pichert JW, Byrne DW, Hedstrom C, Black M, Churchill L, Speroff T.

IRB. 2006 Nov-Dec;28(6):8-14. No abstract available.

PMID:
17849659
48.

The comprehensiveness of family cancer history assessments in primary care.

Murff HJ, Greevy RA, Syngal S.

Community Genet. 2007;10(3):174-80.

PMID:
17575462
49.

Hospital workload and adverse events.

Weissman JS, Rothschild JM, Bendavid E, Sprivulis P, Cook EF, Evans RS, Kaganova Y, Bender M, David-Kasdan J, Haug P, Lloyd J, Selbovitz LG, Murff HJ, Bates DW.

Med Care. 2007 May;45(5):448-55.

PMID:
17446831
50.

The interaction of age and hormone replacement therapy on colon adenoma risk.

Murff HJ, Shrubsole MJ, Smalley WE, Wu H, Shyr Y, Ness RM, Zheng W.

Cancer Detect Prev. 2007;31(2):161-5. Epub 2007 Apr 11.

Supplemental Content

Loading ...
Support Center